WebMD Sees Q2 EPS of $(0.13) vs $(0.10) Est; Revenue $110-115M vs $115.06M Est

WebMD Health Corp.

today announced preliminary financial results for the three months ended June 30, 2012 and updated financial guidance for 2012. Preliminary Results for the Three Months Ended June 30, 2012 WebMD expects that its second quarter revenue, Adjusted EBITDA and net loss will be in line with previously stated financial guidance for the quarter. Revenue for the second quarter is expected to be approximately $112 million. Prior financial guidance for the quarter was $110 million to $115 million. Earnings before interest, taxes, non-cash and other items for the second quarter is expected to be approximately $14 million, or 12.5% of revenue. Prior financial guidance for the quarter was 10% to 12% of revenue. Loss from continuing operations for the second quarter is expected to be approximately $(6.3) million, or $(0.13) per diluted share, or 5.6% of revenue. Prior financial guidance for the quarter was 4% to 6% of revenue. Net loss for the second quarter is expected to be approximately $(5.8) million or $(0.12) per diluted share. Updated 2012 Financial Guidance Based on current visibility into the second half of this year, WebMD has updated its financial guidance for 2012 and expects the following: Revenue of $455 million to $480 million; Adjusted EBITDA of $60 million to $75 million; and Loss from continuing operations of $(12.4) million to $(23.4) million.